The Motley Fool

3 quality ASX shares for growth investors to buy today

I think the Australian share market is home to a good number of shares that have the potential to grow strongly over the next decade.

Three top growth shares that I believe could be great long-term investments are listed below. Here’s why I like them:

Aristocrat Leisure Limited (ASX: ALL)

This gaming technology company’s shares have lost 25% of their value since hitting a 52-week high of $33.06 in July. The selling has been largely due to its strong full year results falling short of the market’s lofty expectations. Whilst this is disappointing for existing shareholders, I think it has created a buying opportunity for the rest of us. Especially given the company’s strong long-term growth potential thanks to its exposure to a digital and social gaming market which is expected to grow at a rapid rate over the next decade.

Bravura Solutions Ltd (ASX: BVS)

One of my favourite growth shares in the mid cap space is this provider of software products and services to clients operating in the wealth management and funds administration industries. The main attraction to the company for me is its popular Sonata product which continues to underpin the company’s strong growth. Growing demand for the Sonata platform led to Bravura Solutions posting a 24% increase in half year revenue to $127.4 million and a 28% lift in half year EBITDA to $23.8 million last month. I expect more of the same in the second half and beyond thanks to the quality of the platform and its sizeable market opportunity.

Cochlear Limited (ASX: COH)

I think this leading global hearing solutions company could be a fantastic long term investment. Last month the company continued its positive run when it posted a 16% lift in half year profits. I expect similarly strong growth over the next decade thanks to the quality of its products, its investments in R&D, wide distribution network, and the expected increase in demand for its hearing implants globally due to ageing populations.

Top 3 Buy-Rated Growth Shares to Buy in March

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked...

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2019."

Each one pays a fully franked dividend. The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies move – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Bravura Solutions Ltd. The Motley Fool Australia has recommended Cochlear Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

One ASX Stock For An Estimated $US22 Billion Marijuana Market

A little-known ASX company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.

And make no mistake – it is coming. To the tune of an estimated $US22 billion.

Cannabis legalisation is sweeping over North America, and full legalisation arrived in Canada in October 2018.

Here’s the best part: we think there’s one ASX stock that’s uniquely positioned to profit immensely from this explosive new industry… taking savvy investors along for what could be one heck of a ride.

AND, this is the first time The Motley Fool Australia has EVER put a BUY recommendation on a marijuana stock.

Simply click below to learn more on how you can profit from the coming cannabis boom.

Click here to find out more